Mead Johnson Nutrition CO (MJN) : Holowesko Partners Ltd. reduced its stake in Mead Johnson Nutrition CO by 18.49% during the most recent quarter end. The investment management company now holds a total of 1,101,743 shares of Mead Johnson Nutrition CO which is valued at $96,832,192 after selling 250,000 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Mead Johnson Nutrition CO makes up approximately 7.68% of Holowesko Partners Ltd.’s portfolio.
Other Hedge Funds, Including , Commerce Bank reduced its stake in MJN by selling 8,140 shares or 10.78% in the most recent quarter. The Hedge Fund company now holds 67,370 shares of MJN which is valued at $5,981,109. Mead Johnson Nutrition CO makes up approx 0.09% of Commerce Bank’s portfolio.Geneva Advisors reduced its stake in MJN by selling 174 shares or 0.66% in the most recent quarter. The Hedge Fund company now holds 26,326 shares of MJN which is valued at $2,337,222. Mead Johnson Nutrition CO makes up approx 0.04% of Geneva Advisors’s portfolio.Janney Montgomery Scott boosted its stake in MJN in the latest quarter, The investment management firm added 639 additional shares and now holds a total of 3,137 shares of Mead Johnson Nutrition CO which is valued at $274,864.Proficio Capital Partners boosted its stake in MJN in the latest quarter, The investment management firm added 72 additional shares and now holds a total of 80 shares of Mead Johnson Nutrition CO which is valued at $7,136. Kwmg added MJN to its portfolio by purchasing 3,761 company shares during the most recent quarter which is valued at $345,485. Mead Johnson Nutrition CO makes up approx 0.18% of Kwmg’s portfolio.
Mead Johnson Nutrition CO closed down -1.21 points or -1.38% at $86.57 with 14,35,558 shares getting traded on Wednesday. Post opening the session at $87.16, the shares hit an intraday low of $85.47 and an intraday high of $87.16 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.